v3.26.1
Condensed Consolidated Statements of Stockholders' Deficit (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive (loss) Income [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2024 $ (186,017) $ 13 $ 1,377,786 $ (356) $ (1,563,460)
Beginning balance,Shares at Dec. 31, 2024   8,413,000      
Vesting of restricted stock (in shares)   172,000      
Shares issued under the employee stock purchase plan, (in shares)   62,000      
Shares issued under the employee stock purchase plan 356   356    
Stock-based compensation 7,344   7,344    
Unrealized loss on investments (46)     (46)  
Foreign currency cumulative translation adjustment 151     151  
Net Income (Loss) (60,714)       (60,714)
Ending balance at Jun. 30, 2025 (238,926) $ 13 1,385,486 (251) (1,624,174)
Ending balance,Shares at Jun. 30, 2025   8,647,000      
Beginning balance at Mar. 31, 2025 (205,884) $ 13 1,381,346 (321) (1,586,922)
Beginning balance,Shares at Mar. 31, 2025   8,568,000      
Vesting of restricted stock (in shares)   17,000      
Shares issued under the employee stock purchase plan, (in shares)   62,000      
Shares issued under the employee stock purchase plan 356   356    
Stock-based compensation 3,784   3,784    
Unrealized loss on investments (20)     (20)  
Foreign currency cumulative translation adjustment 90     90  
Net Income (Loss) (37,252)       (37,252)
Ending balance at Jun. 30, 2025 (238,926) $ 13 1,385,486 (251) (1,624,174)
Ending balance,Shares at Jun. 30, 2025   8,647,000      
Beginning balance at Dec. 31, 2025 (292,926) $ 14 1,466,488 71 (1,759,499)
Beginning balance,Shares at Dec. 31, 2025   18,311,000      
Vesting of restricted stock (in shares)   234,000      
Issuance of common stock under Open Market Sale Agreement, net of issuance costs (in shares)   2,994,000      
Issuance of common stock under Open Market Sale Agreement, net of issuance costs 19,827   19,827    
Issuance of common stock and warrants in private placement offering, net of issuance costs (in shares)   1,030,000      
Issuance of common stock and warrants in private placement offering, net of issuance costs 26,866   26,866    
Shares issued under the employee stock purchase plan, (in shares)   111,000      
Shares issued under the employee stock purchase plan 574   574    
Stock-based compensation 4,936   4,936    
Unrealized loss on investments (5)     (5)  
Foreign currency cumulative translation adjustment (25)     (25)  
Net Income (Loss) (89,415)       (89,415)
Ending balance at Jun. 30, 2026 (330,168) $ 14 1,518,691 41 (1,848,914)
Ending balance,Shares at Jun. 30, 2026   22,680,000      
Beginning balance at Mar. 31, 2026 (265,646) $ 14 1,516,188 43 (1,781,891)
Beginning balance,Shares at Mar. 31, 2026   22,544,000      
Vesting of restricted stock (in shares)   25,000      
Shares issued under the employee stock purchase plan, (in shares)   111,000      
Shares issued under the employee stock purchase plan 574   574    
Stock-based compensation 1,929   1,929    
Unrealized loss on investments (2)     (2)  
Foreign currency cumulative translation adjustment 0        
Net Income (Loss) (67,023)       (67,023)
Ending balance at Jun. 30, 2026 $ (330,168) $ 14 $ 1,518,691 $ 41 $ (1,848,914)
Ending balance,Shares at Jun. 30, 2026   22,680,000